Wake Up Narcolepsy Inaugural Bridging Perspectives Convening Recap

Worldwide Step Up For Sleep 2025 Recap

Wake Up Narcolepsy Announces AASM Foundation 2026 Grant Partnership

Join Us for October’s Brown Bag Webinar – Advocating with Confidence in the Educational System

Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses

WUN Launches Translated Narcolepsy Resources Webpage for World Narcolepsy Day 2025

WUN Signs Community Support Letter for the Rare Pediatric Disease PRV Program

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd